Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Combined Effects of Bioactive Compounds (ARMOLIPID PLUS ®) on Lipid Profile and Clinical Criteria of Metabolic Syndrome in Patients With Serum Elevated LDL-C

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01562080
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:22.029649+00:00
Published At
2013-02-28T00:00:00+00:00
Record Updated At
2013-02-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hyperlipidemia", "Low-density-lipoprotein-type", "Elevated Triglycerides"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-02-28"
protocolSection.identificationModule.nctId
"NCT01562080"
protocolSection.identificationModule.officialTitle
"Combined Effects of Bioactive Compounds (ARMOLIPID PLUS \u00ae) on Lipid Profile and Clinical Criteria of Metabolic Syndrome in Patients With Serum Elevated LDL-C"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hyperlipidemia (protocolSection.conditionsModule.conditions)
  • Low-density-lipoprotein-type (protocolSection.conditionsModule.conditions)
  • Elevated Triglycerides (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.